
A US hedge fund, Elliott Associates has gone to court challenging through an injunction, the planned merger of the companies calling it unfair to shareholders. Elliott Associates is the third largest shareholder in Samsung’s construction business Samsung C&T. The activist investing firm holds a 7.12% stake in Samsung C&T and is currently urging other shareholders in the firm to oppose the takeover bid. Cheil which announced the deal a month ago plans to takeover C&T by issuing 0.35 new Cheil shares for each C&T share. After the proposed deal, Lee would become the largest shareholder in the combined entity with a 16.5 percent stake.
This will be an interesting duel to watch going forward. The Economist article highlighted that Samsung was betting on next-generation batteries, medical equipment and biotechnology to grow revenues in the future with plans to replicate the dominance in ship making in drug making.




















